VEGFA and non-small cell lung carcinoma: Compared with normal lung tissue, the expression of PPARβ/δ, Cox-2, c-PLA, PGES, and VEGF was increased in human non-small cell lung cancer, and tumor progression was associated with upregulation of PPARβ/δ, increased VEGF levels, and activation of the PI3K/Akt pathway.